By Sheri Kasprzak
New York, Oct. 4 - Genomic Health, Inc. said it closed a private placement for $4,999,992.
The company sold 416,666 shares at $12.00 each to Incyte Corp. as part of an agreement the two companies entered in March 2001 following an offering of series C preferred stock.
Under the terms of the agreement, Genomic had the right to cause Incyte to buy up to $5 million in common stock at the price per share of Genomic's initial public offering.
In its IPO, closed on Sept. 28, Genomic sold 5,016,667 shares at $12.00 each.
Based in Redwood City, Calif., Genomic makes genomic-based clinical diagnostics tests.
| Issuer: | Genomic Health, Inc.
|
| Issue: | Stock
|
| Amount: | $4,999,992
|
| Shares: | 416,666
|
| Price: | $12.00
|
| Warrants: | No
|
| Investor: | Incyte Corp.
|
| Settlement date: | Oct. 4
|
| Stock price: | $11.55 at close Oct. 4
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
